Kymera Therapeutics (KYMR) Current Leases (2019 - 2026)
Kymera Therapeutics (KYMR) recorded Current Leases of $1.58 million in Q2 2026, down 17.0% from $1.9 million a year earlier and down 7.3% from the prior quarter.
Powered by 
Analysis
Kymera Therapeutics (KYMR) Current Leases (2019 - 2026) Analysis & Trends
At the end of FY2025, Kymera Therapeutics reported Current Leases of $1.82 million, up 19.6% from FY2024.
- Annual Current Leases has a five-year compound annual growth rate of 21.4% (FY2020 to FY2025).
- Across earlier years, Current Leases came in at $1.52 million in FY2024 (+18.9%), $1.28 million in FY2023 (-9.3%), $1.41 million in FY2022 (+23.7%) and $1.14 million in FY2021 (+65.2%).
- The Q2 2026 figure is the lowest quarterly Current Leases since Q1 2025.
- On a year-over-year basis, Current Leases rose in seven of the last eight quarters, with growth averaging 29.2%.
- Peak year-over-year performance for Current Leases in the last five years was growth of 91.5% in Q2 2025, against a decline of 19.4% in Q2 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $1.7 million (Q1 2026), $1.82 million (Q4 2025) and $1.89 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | - |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | - |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 274.00 Mn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -2.32 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | - |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | - |
| 10 | Kymera Therapeutics | 9.27 Bn | 6.58 Bn | - | 1.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.58 Mn |
| Mar 31, 2026 | 1.70 Mn |
| Dec 31, 2025 | 1.82 Mn |
| Sep 30, 2025 | 1.89 Mn |
| Jun 30, 2025 | 1.90 Mn |
| Mar 31, 2025 | 1.56 Mn |
| Dec 31, 2024 | 1.52 Mn |
| Sep 30, 2024 | 1.34 Mn |
| Jun 30, 2024 | 992,000.00 |
| Mar 31, 2024 | 1.13 Mn |
| Dec 31, 2023 | 1.28 Mn |
| Sep 30, 2023 | 1.01 Mn |
| Jun 30, 2023 | 1.23 Mn |
| Mar 31, 2023 | 1.34 Mn |
| Dec 31, 2022 | 1.41 Mn |
| Sep 30, 2022 | 1.10 Mn |
| Jun 30, 2022 | 1.16 Mn |
| Mar 31, 2022 | 1.09 Mn |
| Dec 31, 2021 | 1.14 Mn |
| Sep 30, 2021 | 1.19 Mn |
API Access
Kymera Therapeutics Current Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-leases&ticker=KYMR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-leases", "ticker": "KYMR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-leases&ticker=KYMR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();